切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2024, Vol. 13 ›› Issue (05) : 423 -430. doi: 10.3877/cma.j.issn.2095-3224.2024.05.011

经验交流

直肠肿瘤术后直肠阴道瘘的外科治疗
邱小原1, 刘雨馨1, 李珂璇1, 林国乐1,(), 邱辉忠1, 安燚2,()   
  1. 1.100730 中国医学科学院北京协和医院基本外科
    2.100007 北京市第六医院肿瘤外科
  • 收稿日期:2024-06-23 出版日期:2024-10-25
  • 通信作者: 林国乐, 安燚
  • 基金资助:
    中央高水平医院临床科研专项(No. 2022-PUMCH-C-005)

Surgical treatment for rectovaginal fistula following rectal tumor surgery

Xiaoyuan Qiu1, Yuxin Liu1, Kexuan Li1, Guole Lin1,(), Huizhong Qiu1, Yi An2,()   

  1. 1.Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China
    2.Department of Oncology Surgery,Beijing Sixth Hospital, Beijing 100007, China
  • Received:2024-06-23 Published:2024-10-25
  • Corresponding author: Guole Lin, Yi An
引用本文:

邱小原, 刘雨馨, 李珂璇, 林国乐, 邱辉忠, 安燚. 直肠肿瘤术后直肠阴道瘘的外科治疗[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 423-430.

Xiaoyuan Qiu, Yuxin Liu, Kexuan Li, Guole Lin, Huizhong Qiu, Yi An. Surgical treatment for rectovaginal fistula following rectal tumor surgery[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(05): 423-430.

目的

探讨直肠肿瘤手术后出现直肠阴道瘘(RVF)的不同外科治疗方法的成功率和适应证。

方法

回顾性收集2014 年1 月至2022 年6 月期间北京协和医院收治的直肠肿瘤术后出现RVF 并住院治疗患者的临床资料,记录治疗方案,观察RVF 治愈情况。

结果

研究共入组37 例患者,平均年龄(58±13)岁。其中恶性肿瘤28 例,良性肿瘤9 例。出现RVF 接受1 次、2 次、3 次手术治疗患者分别为18 例(48.6%)、10 例(27.0%)、3 例(8.1%),手术方式包括转流术、经肛门RVF 修补术、经肛门联合经肛门内镜下RVF 修补术、经肛门括约肌RVF 修补术(Mason 术)、腹腔镜直肠前切除RVF 修补术(Dixon 术/Hartmann 术)、经阴道修补术、内镜RVF 修补术、盆腔引流术。最终7 例(18.9%)患者RVF 得到治愈,还纳造口,中位还纳时间距直肠手术37 个月,距发现RVF 29 个月。还纳成功患者中5 例为良性肿瘤,2 例为恶性肿瘤,良恶性肿瘤还纳成功率差异有统计学意义(P=0.005)。

结论

多数直肠肿瘤术后RVF 患者经历多次手术、仍无法还纳造口;部分患者在造口还纳后仍有再发RVF 风险。直肠恶性肿瘤术后发生的复杂型RVF 治疗成功率较良性肿瘤低。RVF修补方式应根据瘘口位置、大小、复杂程度选择:瘘口位置较高的患者,选择经腹入路修补;经腹手术困难、瘘口位置较低的患者,选择经肛门、经会阴途径修补,或多入路联合修补。对于有RVF 高危因素的患者,在初始手术时即应重视预防RVF。

Objective

To explore the difference and indication between various surgical treatment methods for rectovaginal fistula (RVF) that occurs after rectal tumor surgery.

Methods

Retrospectively collected clinical data of patients who developed RVF following rectal tumor surgery and were hospitalized for treatment in Peking Union Medical College Hospital from January 2014 to June 2022. The treatment plans,the outcomes of RVF healing were recorded.

Results

A total of 37 patients were included in the study,with an average age of (58 ± 13) years. Among them,twenty-eight had malignant tumors and 9 had benign tumors. Patients underwent 1,2,or 3 times of surgical treatments for RVF in 18 (48.6%),10 (27.0%),and 3 (8.1%) cases,respectively. Surgical methods included diversion surgery,transanal RVF repair,transanal combined with endoscopic RVF repair,transanal sphincteric RVF repair (Mason procedure),laparoscopic anterior rectal resection RVF repair (Dixon/Hartmann procedure),transvaginal repair,endoscopic RVF repair,and pelvic drainage surgery. Ultimately,seven patients’ (18.9%) RVF were cured and got stoma reversed,with a median reversal time of 37 months from the rectal surgery and 29 months from RVF discovery. Among the successfully reversed patients,five patients had benign tumors and 2 patients had malignant tumors,with a significant difference in reversal success rates between benign and malignant tumors (P=0.005).

Conclusion

RVF following rectal tumor surgery causing lots of patients undergo multiple surgeries and are still unable to have their stomas reversed. Some patients face the risk of recurrent RVF even after stoma reversal. The success rate of treating complex RVF after malignant rectal tumor surgery is lower than that of benign tumors. The choice of RVF repair method should be based on the location,size,and complexity of the fistula. For fistulas located higher up,an abdominal approach is preferred. For cases where abdominal surgery is difficult or the fistula is located lower,transanal or perineal approach or a combined multi-approach repair is recommended. For patients with high-risk factors for RVF,prevention should be emphasized during the initial surgery.

表1 直肠良性肿瘤患者RVF 发生及治疗情况
续表
序号 肿瘤病理 手术方式 RVF表现 RVF修补手术 最终结局
10 直肠癌 TaTME+回肠造口术 术后1个月阴道排液 ①回肠造口还纳术+横结肠造口术 未还纳
11 直肠癌 Lap Dixon+回肠造口术 术后1个月阴道排液 ①经肛门内镜联合经阴道直肠阴道瘘修补术 未还纳
12 直肠癌 Lap Dixon+回肠造口术 还纳后2个月阴道排便 ①横结肠造口术 未还纳
13 直肠癌 Lap Dixon+回肠造口+经肛门直肠肿物活检术 术后8个月拟行造口还纳时行美兰试验(+) ①经肛门内镜联合经阴道直肠阴道瘘修补术 未还纳
14 直肠癌 Lap Dixon+横结肠造口术 术后16天阴道排便 ①腹腔镜探查+阴道置管+盆腔置管 未还纳
②Mason
15 直肠癌 Lap Dixon+回肠造口(经阴道NOSES)术 术后20天阴道排气 ①经阴道黏膜肌推移瓣修补术 未还纳
16 直肠癌 Lap Dixon+横结肠造口术 术后23个月阴道排气排液a ①横结肠造口术 未还纳
②经肛门内镜下直肠阴道瘘修补术
17 直肠癌 LapHartmann+右半结肠切除术 术后35天阴道排液 ①观察 -
18 直肠癌 Lap Dixon+回肠造口术 还纳后50天阴道排气排液 ①横结肠造口术 未还纳
②经肛门内镜联合经阴道直肠阴道瘘修补术
19 直肠癌 Lap Dixon+回肠造口术 术后6个月拟行造口还纳时行美兰试验(+) ①经肛门内镜联合经阴道直肠阴道瘘修补术 未还纳
②经阴道直肠阴道瘘修补术
20 直肠癌 Lap Dixon+回肠造口术 还纳后15个月阴道排液 ①横结肠造口术 未还纳
②经肛门内镜联合经阴道直肠阴道瘘修补术
③经肛门内镜联合经阴道直肠阴道瘘修补术
21 直肠癌 Lap Dixon术 术后18天阴道排气排便 ①横结肠造口术 未还纳
②Mason
22 直肠癌 Lap Dixon+回肠造口术 还纳后10个月阴道排液 ①横结肠造口术 未还纳
23 直肠癌 开腹Dixon术 术后8天阴道排液 ①横结肠造口术 造口后
②经肛门内镜下直肠阴道瘘修补 69个月
③经肛门内镜下直肠阴道瘘修补 还纳
24 直肠癌 开腹Dixon术 术后20天阴道排气排便 ①经肛门内镜下直肠阴道瘘修补术b 未还纳
②横结肠造口术
③Mason
25 直肠癌 Lap Dixon+回肠造口术 术后6个月拟行造口还纳时行美兰试验(+) ①观察 未还纳
26 直肠癌 TaTME+回肠造口术 术后5天阴道排液 ①观察 未还纳
27 直肠癌 Lap Dixon+回肠造口术 术后13天阴道排气排液 ①观察 未还纳
28 直肠癌 Lap Dixon+横结肠造口术 术后10个月拟行造口还纳时行消化道造影(+)c ①观察 未还纳
29 直肠癌 Lap Dixon+横结肠造口术 还纳后13个月阴道排便 ①回肠造口术 未还纳
②Mason
30 直肠癌 Lap Dixon+回肠造口术 还纳后24个月阴道排气排便 ①横结肠造口术 未还纳
31 直肠癌 Lap Dixon术 术后81个月阴道排气排便 ①横结肠造口术 未还纳
32 直肠癌 Lap Dixon+横结肠造口术 还纳后14个月阴道排气排便 ①横结肠造口术 未还纳
②经肛门内镜下直肠阴道瘘修补术
33 直肠癌 Lap Dixon+经阴道NOSES术 术后30天阴道排液 ①横结肠造口+经肛门联合经阴道直肠阴道瘘修补 未还纳
序号 肿瘤病理 手术方式 RVF表现 RVF修补手术 最终结局
34 直肠癌 开腹Dixon+子宫切除术 术后32天阴道排液 ①横结肠造口术 未还纳
②肠镜下瘘口金属夹封闭d
35 直肠癌 Lap Dixon+回肠造口术 还纳后17个月阴道排液e ①Lap Hartmann+阴道及附件切除 -
36 直肠癌 Lap Dixon+经阴道NOSES术 术后20天阴道排便 ①横结肠造口术 还纳
②腹腔镜直肠阴道瘘修补(Dixon)
37 直肠癌 Lap Dixon术 术后74个月阴道排便f ①直肠癌复发灶Dixon+回肠造口术 造口后4个月还纳
表3 手术方式及RVF 治愈情况
[1]
Corte,Maggiori,Treton,et al. Rectovaginal fistula: what is the optimal strategy?: an analysis of 79 patients undergoing 286 procedures[J].Ann Surg,2015,262(5): 855-860; discussion 860-851.
[2]
Moraes Rda S,Malafaia O,Telles JE,et al. Transanal endoscopic microsurgery in the treatment of rectal tumors: a prospective study in 50 patients[J]. Arq Gastroenterol,2008,45(4): 268-274.
[3]
Kazi MK,Gori J,Engineer R,et al. Incidence and treatment outcomes of rectovaginal fistula after rectal cancer resection[J]. Female Pelvic Med Reconstr Surg,2022,28(2): 115-120.
[4]
Zheng H,Guo T,Wu Y,et al. Rectovaginal fistula after low anterior resection in Chinese patients with colorectal cancer[J]. Oncotarget,2017,8(42): 73123-73132.
[5]
Matthiessen P,Hansson L,Sjödahl R,et al. Anastomotic-vaginal fistula(AVF) after anterior resection of the rectum for cancer--occurrence and risk factors[J]. Colorectal Dis,2010,12(4): 351-357.
[6]
张斌,赵克,刘泉龙,等. 低位直肠癌腹腔镜经括约肌间切除术后并发症及其处理[J]. 中华胃肠外科杂志,2017,20(4): 432-438.Zhang B,Zhao K,Liu QL,et al. Treatment of complications after laparoscopic intersphincteric resection for low rectal cancer[J]. Chin J Gastrointest Surg,2017,20(4): 432-438.
[7]
Dindo D,Demartines N,Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey[J]. Ann Surg,2004,240(2): 205-213.
[8]
林国乐,邱辉忠,蒙家兴,等. 医源性直肠阴道瘘的成因分析和治疗方法探讨[J]. 中国普通外科杂志,2006,15(9): 685-688.
[9]
顾晋,王林. 低位直肠癌术后直肠阴道瘘的诊断和治疗[J]. 中华外科杂志,2006,44(23): 1587-1591.Gu J,Wang L. The diagnosis and treatment of rectovaginal fistula after the low rectal cancer resection[J]. Chin J Surg,2006,44(23): 1587-1591.
[10]
Abu Gazala M,Wexner SD. Management of rectovaginal fistulas and patient outcome[J]. Expert Rev Gastroenterol Hepatol,2017,11(5):461-471.
[11]
Lohsiriwat V,Jitmungngan R. Rectovaginal fistula after low anterior resection: prevention and management[J]. World J Gastrointest Surg,2021,13(8): 764-771.
[12]
Alhassan FA,Cohen-Bacry M,Faucheron JL. Management of rectovaginal fistula: surgery is not always necessary[J]. Tech Coloproctol,2022,26(6): 513-514.
[13]
Barugola G,Bertocchi E,Leonardi A,et al. Post surgical rectovaginal fistula: who really benefits from stoma diversion?[J]. Updates Surg,2021,73(1): 165-171.
[14]
王振峰,赵传杰,李秀阳,等. 分期应用Mason 术治疗复发性直肠阴道瘘[J]. 中华胃肠外科杂志,2010,13(1): 75-75.
[15]
Piekarski JH,Jereczek-Fossa BA,Nejc D,et al. Does fecal diversion offer any chance for spontaneous closure of the radiation-induced rectovaginal fistula?[J]. Int J Gynecol Cancer,2008,18(1): 66-70.
[16]
张迪,陈华显,李娟,等. 手术治疗直肠阴道瘘34 例临床疗效分析[J]. 中华胃肠外科杂志,2016,19(12): 1416-1418.
[17]
Chen W,Chen X,Lin G,et al. Successful repair of recurrent rectovaginal fistula by stratified suture using transanal endoscopic microsurgery: a CARE-compliant case report[J]. Medicine (Baltimore),2016,95(36): e4600.
[18]
Darwood RJ,Borley NR. TEMS: an alternative method for the repair of benign recto-vaginal fistulae[J]. Colorectal Dis,2008,10(6): 619-620.
[19]
邱辉忠. 经切开肛门括约肌的直肠阴道瘘修补术(附4 例报告)[J].中国实用外科杂志,1998,(5): 42.
[20]
邱辉忠,陆君阳,周皎琳. 经肛门括约肌径路的直肠阴道瘘修补术[J]. 中华胃肠外科杂志,2015,18(4): 358-360.Qiu HZ,Lu JY,Zhou JL. Transsphincteric approach for rectovaginal fistulas repair[J]. Chin J Gastrointest Surg,2015,18(4): 358-360.
[21]
Emoto S,Nozawa H,Yoneyama S,et al. Rectovaginal fistula after low anterior resection for rectal cancer healed by nonoperative treatment[J].Int J Surg Case Rep,2017,(41): 121-123.
[22]
Ohta H,Hashimoto K,Mizukuro T,et al. Successful laparoscopyassisted repair of a rectovaginal fistula after low anterior resection for rectal cancer: a report of two cases[J]. Surg Case Rep,2021,7(1): 68.
[23]
佟伟华,王权. taTME 在直肠再次手术中的临床应用(附10 例报道)[J]. 结直肠肛门外科,2022,28(1): 69-72.
[24]
Antoniou SA,Agresta F,Garcia Alamino JM,et al. European Hernia Society guidelines on prevention and treatment of parastomal hernias[J]. Hernia,2018,22(1): 183-198.
[25]
Qin Q,Huang B,Cao W,et al. Bowel dysfunction after low anterior resection with neoadjuvant chemoradiotherapy or chemotherapy alone for rectal cancer: a cross-sectional study from China[J]. Dis Colon Rectum,2017,60(7): 697-705.
[26]
Woo IT,Park JS,Choi GS,et al. Optimal strategies of rectovaginal fistula after rectal cancer surgery[J]. Ann Surg Treat Res,2019,97(3):142-148.
[27]
Huang MJ,Ye DX,Lin Y,et al. A nomogram for predicting rectovaginal fistula after low anterior resection for rectal cancer[J].Surg Today,2020,50(10): 1206-1212.
[28]
黄胜辉,池畔,林惠铭,等. 直肠癌保肛术后迟发型吻合口瘘的影响因素及临床特点[J]. 中华胃肠外科杂志,2016,19(4): 390-395.Huang SH,Chi P,Lin HM,et al. Risk factors and clinical features of delayed anastomotic fistula following sphincter-preserving surgery for rectal cancer[J]. Chin J Gastrointest Surg,2016,19(4): 390-395.
[29]
王影,阎庆辉,王刚成,等. 自体组织预防盆腔多脏器联合切除术后出现直肠阴道瘘的临床疗效[J]. 中华胃肠外科杂志,2024,27(3):278-282.Wang Y,Yan QH,Wang GC,et al. Clinical efficacy of autologous biological patch in preventing rectovaginal fistula after pelvic exenteration[J]. Chin J Gastrointest Surg,2024,27(3): 278-282.
[1] 王振宁, 杨康, 王得晨, 邹敏, 归明彬, 王雅楠, 徐明. 机器人与腹腔镜手术联合经自然腔道取标本对中低位直肠癌患者远期疗效比较[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 437-442.
[2] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[3] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[4] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[5] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[6] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[7] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[8] 庄宝雄, 邓海军. 单孔+1腹腔镜直肠癌侧方淋巴结清扫术[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 601-601.
[9] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[10] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[11] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
[12] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[13] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
[14] 陈杰, 武明胜, 李一金, 李虎, 向源楚, 荣新奇, 彭健. 低位直肠癌冷冻治疗临床初步分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 494-498.
[15] 黄海洋, 邝永龙, 陈嘉胜. 基层医院结直肠肿瘤经自然腔道取标本手术30 例分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 510-518.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?